Unique products
from deCODE science

We apply our discoveries and capabilities in genetics to offer customers and partners market-leading diagnostic tests, personal genome scans, and tools for analyzing and visualizing genomic information


deCODE genetics employs its discoveries in a growing range of market-leading DNA-based risk assessment tests that enable individuals, working with their physician, to better understand their risk of disease and to empower better prevention, targeted screening and earlier intervention. deCODE's tests for assessing risk of common diseases are for clinical use and can be ordered with the authorization of physicians or other healthcare professionals, and many of these tests such as those for heart attack and type 2 diabetes are reimbursed by health insurance companies in the U.S. Click on the buttons below to find out more about these tests and how to order them.

OUR DIAGNOSTIC TESTS



deCODE T2 defines genetic risk for T2D, independent of family history and obesity. By knowing and understanding the genetic risk, it may be possible to take actions that reduce or minimize the likelihood of an individual developing diabetes.

More information and order forms 

 



deCODE BreastCancer is a reference laboratory DNA test for assessing individual risk of the common forms of breast cancer. The common forms of the disease account for approximately 95% of all breast cancers.

More information and order forms 

 



deCODE ProstateCancer is a reference laboratory DNA test for assessing an inherited risk factor for Prostate Cancer.

More information and order forms 

 



deCODE Glaucoma is a reference laboratory DNA test for assessing an inherited risk factor for exfoliation glaucoma.

More information and order forms 

 



deCODE MI detects previously unrecognized genetic risk of MI that appears to be in addition to welll known risk factors such as elevated cholesterol and hypertension. The test may be positive even in patients of families without history of heart attacks.

More information and order forms 

 



deCODE AF offers a novel means of identifying those who may benefit from outpatient cardiac monitoring after leaving the hospital.

More information and order forms 

 

OUR PERSONAL GENETIC SCAN



deCODEme Complete Scan analyses genetic risk factors for 48 diseases ranging from heart attack and diabetes to lung cancer and traits like ABO bloodtypes, eye color and male pattern baldness.

deCODEme Complete Scan